Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125018 · ClinicalTrials.gov registry record · NA
Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03125018 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 13 participants.
The verdict
NCT03125018, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.
Interventions
- DEVICE LNCS ADTX Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-09-30 |
| Est. Completion | 2014-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125018
The ClinicalTrials.gov registry entry for NCT03125018 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LNCS ADTX Sensor is the first listed.
NCT03125018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03125018 about?
NCT03125018 is a clinical study titled "Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)". In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory ...
What is the current status of trial NCT03125018?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2014-09-30. Estimated completion is 2014-10-09.
What interventions are being tested in trial NCT03125018?
The interventions under investigation include: LNCS ADTX Sensor (DEVICE).
Who is sponsoring clinical trial NCT03125018?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.